188 related articles for article (PubMed ID: 22542172)
21. [Prognosis after complete surgical resection for non-small cell lung cancer based on the staging classification].
Pfannschmidt J; Muley T; Hoffmann H; Bülzebruck H; Dienemann H
Dtsch Med Wochenschr; 2006 Nov; 131(47):2643-8. PubMed ID: 17109272
[TBL] [Abstract][Full Text] [Related]
22. Prognostic value of visceral pleural invasion in resected non-small cell lung cancer diagnosed by using a jet stream of saline solution.
Maruyama R; Shoji F; Okamoto T; Miyamoto T; Miyake T; Nakamura T; Ikeda J; Asoh H; Yamaguchi M; Yoshino I; Ichinose Y
J Thorac Cardiovasc Surg; 2004 Jun; 127(6):1587-92. PubMed ID: 15173711
[TBL] [Abstract][Full Text] [Related]
23. Lymphovascular invasion is an independent prognostic factor in prostatic adenocarcinoma.
Cheng L; Jones TD; Lin H; Eble JN; Zeng G; Carr MD; Koch MO
J Urol; 2005 Dec; 174(6):2181-5. PubMed ID: 16280760
[TBL] [Abstract][Full Text] [Related]
24. Staging and resection of lung cancer with minimal invasion of the adjacent lobe.
Demir A; Gunluoglu MZ; Sansar D; Melek H; Dincer SI
Eur J Cardiothorac Surg; 2007 Dec; 32(6):855-8. PubMed ID: 17936002
[TBL] [Abstract][Full Text] [Related]
25. Clinicopathologic factors influencing postoperative prognosis in patients with small-sized adenocarcinoma of the lung.
Inoue M; Takakuwa T; Minami M; Shiono H; Utsumi T; Kadota Y; Nasu T; Aozasa K; Okumura M
J Thorac Cardiovasc Surg; 2008 Apr; 135(4):830-6. PubMed ID: 18374763
[TBL] [Abstract][Full Text] [Related]
26. Pre- and post-operative serum carcinoembryonic antigen in primary lung adenocarcinoma.
Nonaka M; Kataoka D; Yamamoto S; Bito A; Matsuoka J; Kawada T; Takaba T
Ann Thorac Cardiovasc Surg; 2004 Oct; 10(5):281-4. PubMed ID: 15563262
[TBL] [Abstract][Full Text] [Related]
27. Association of immunoreactive hepatocyte growth factor with poor survival in resectable non-small cell lung cancer.
Siegfried JM; Weissfeld LA; Singh-Kaw P; Weyant RJ; Testa JR; Landreneau RJ
Cancer Res; 1997 Feb; 57(3):433-9. PubMed ID: 9012470
[TBL] [Abstract][Full Text] [Related]
28. [Risk factors of recurrence in resected stage I non-small cell lung cancer].
Kita H; Koshiishi Y; Masui K; Fujita A; Ootsuka K; Furuyashiki G; Nakazato Y; Takei H; Goya T
Kyobu Geka; 2007 Sep; 60(10):883-7. PubMed ID: 17877005
[TBL] [Abstract][Full Text] [Related]
29. Prognostic significance of a histologic subtype in small adenocarcinoma of the lung: the impact of nonbronchioloalveolar carcinoma components.
Sakao Y; Miyamoto H; Sakuraba M; Oh T; Shiomi K; Sonobe S; Izumi H
Ann Thorac Surg; 2007 Jan; 83(1):209-14. PubMed ID: 17184664
[TBL] [Abstract][Full Text] [Related]
30. Lymphatic vessel invasion is a significant prognostic indicator in stage IA lung adenocarcinoma.
Funai K; Sugimura H; Morita T; Shundo Y; Shimizu K; Shiiya N
Ann Surg Oncol; 2011 Oct; 18(10):2968-72. PubMed ID: 21512862
[TBL] [Abstract][Full Text] [Related]
31. [Multivariate survival analysis of 899 patients with non-small cell lung cancer after complete resection].
Wei WD; Wen ZS; Su XD; Lin P; Rong TH; Chen LK
Ai Zheng; 2007 Nov; 26(11):1231-6. PubMed ID: 17991324
[TBL] [Abstract][Full Text] [Related]
32. Prognostic impact of the primary tumor location based on the hilar structures in non-small cell lung cancer with mediastinal lymph node metastasis.
Ito M; Yamashita Y; Miyata Y; Ohara M; Tsutani Y; Ikeda T; Misumi K; Harada H; Omori K
Lung Cancer; 2012 Apr; 76(1):93-7. PubMed ID: 22285532
[TBL] [Abstract][Full Text] [Related]
33. Telomerase activity as a prognostic indicator in stage I non-small cell lung cancer.
Marchetti A; Bertacca G; Buttitta F; Chella A; Quattrocolo G; Angeletti CA; Bevilacqua G
Clin Cancer Res; 1999 Aug; 5(8):2077-81. PubMed ID: 10473089
[TBL] [Abstract][Full Text] [Related]
34. Pathologic stage I non-small cell lung cancer with high levels of preoperative serum carcinoembryonic antigen: clinicopathologic characteristics and prognosis.
Matsuguma H; Nakahara R; Igarashi S; Ishikawa Y; Suzuki H; Miyazawa N; Honjo S; Yokoi K
J Thorac Cardiovasc Surg; 2008 Jan; 135(1):44-9. PubMed ID: 18179917
[TBL] [Abstract][Full Text] [Related]
35. Pathological vascular invasion and tumor differentiation predict cancer recurrence in stage IA non-small-cell lung cancer after complete surgical resection.
Shimada Y; Saji H; Yoshida K; Kakihana M; Honda H; Nomura M; Usuda J; Kajiwara N; Ohira T; Ikeda N
J Thorac Oncol; 2012 Aug; 7(8):1263-70. PubMed ID: 22673056
[TBL] [Abstract][Full Text] [Related]
36. Predictive factors for survival in surgically resected clinical IA peripheral adenocarcinoma of the lung.
Sakao Y; Nakazono T; Sakuragi T; Natsuaki M; Itoh T
Ann Thorac Surg; 2004 Apr; 77(4):1157-61; discussion 1161-2. PubMed ID: 15063225
[TBL] [Abstract][Full Text] [Related]
37. High expression of CHRNA1 is associated with reduced survival in early stage lung adenocarcinoma after complete resection.
Chang PM; Yeh YC; Chen TC; Wu YC; Lu PJ; Cheng HC; Lu HJ; Chen MH; Chou TY; Huang CY
Ann Surg Oncol; 2013 Oct; 20(11):3648-54. PubMed ID: 23775407
[TBL] [Abstract][Full Text] [Related]
38. [Analysis of prognostic factors in 1826 patients with completely resected non-small cell lung cancer].
Gao YS; Xing XZ; Shao K; Feng XL; He J
Zhonghua Zhong Liu Za Zhi; 2008 Feb; 30(2):134-7. PubMed ID: 18646698
[TBL] [Abstract][Full Text] [Related]
39. Prognostic impact of FDG-PET in surgically treated pathological stage I lung adenocarcinoma.
Higuchi M; Hasegawa T; Osugi J; Suzuki H; Gotoh M
Ann Thorac Cardiovasc Surg; 2014; 20(3):185-91. PubMed ID: 23603641
[TBL] [Abstract][Full Text] [Related]
40. The prognostic role of pathologic invasive component size, excluding lepidic growth, in stage I lung adenocarcinoma.
Tsutani Y; Miyata Y; Mimae T; Kushitani K; Takeshima Y; Yoshimura M; Okada M
J Thorac Cardiovasc Surg; 2013 Sep; 146(3):580-5. PubMed ID: 23778085
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]